Mechanisms of glucagon-like-peptide 1 in the brain beyond metabolic effects
Among the 60 participants treated with GSBR-1290, only one (2.8%, from the T2DM group) discontinued the study due to drug-related adverse events (AEs)
Free radicals accelerate skin aging, create dark spots, and trigger inflammation
This research reveals that IGF-1 administration can prolong life and reduce disability Glucocorticoid Signaling Glucocorticoids, secreted primarily by the adrenal glands, are important clinical drugs used to control pain and reduce inflammation in autoimmune diseases, neurological injury, cancer, and more
Environmental Feedback from the MDT group have highlighted special considerations for setting up group GLP-1 RA starts in terms of ergonomics and environment